What is he best known for?
The fields of study he is best known for:
His primary areas of study are Microbiology, Escherichia coli, Virulence, Epidemiology and Urinary system.
In Microbiology, Carl F. Marrs works on issues like Virology, which are connected to Molecular epidemiology.
His Virulence research is within the category of Gene.
His Gene study contributes to a more complete understanding of Genetics.
The various areas that Carl F. Marrs examines in his Epidemiology study include Surgery, Tuberculosis, Colonization and Risk factor.
His Urinary system research is multidisciplinary, incorporating elements of Feces and Bacteria.
His most cited work include:
- Prevalence of Antibiotic Resistance in Drinking Water Treatment and Distribution Systems (319 citations)
- Identification of risk factors for extrapulmonary tuberculosis (257 citations)
- Wastewater treatment contributes to selective increase of antibiotic resistance among Acinetobacter spp. (219 citations)
What are the main themes of his work throughout his whole career to date?
Carl F. Marrs spends much of his time researching Microbiology, Genetics, Haemophilus influenzae, Gene and Virulence.
His Microbiology research includes themes of Bacterial adhesin, Pilus, Escherichia coli, Virology and Bacteria.
His Escherichia coli research focuses on subjects like Urinary system, which are linked to Vagina.
In his research on the topic of Genetics, Genetic diversity is strongly related with Mycobacterium tuberculosis.
His research in Haemophilus influenzae intersects with topics in Colonization and Otitis.
His research integrates issues of Dot blot, DNA–DNA hybridization and Pathogenesis in his study of Virulence.
He most often published in these fields:
- Microbiology (57.52%)
- Genetics (30.07%)
- Haemophilus influenzae (27.45%)
What were the highlights of his more recent work (between 2011-2021)?
- Microbiology (57.52%)
- Haemophilus influenzae (27.45%)
- Antibiotic resistance (9.80%)
In recent papers he was focusing on the following fields of study:
Carl F. Marrs mostly deals with Microbiology, Haemophilus influenzae, Antibiotic resistance, Antibiotics and Escherichia coli.
His Microbiology research incorporates themes from Plasmid, Gene, Genotype, Virulence and Bacteria.
The Amplicon research Carl F. Marrs does as part of his general Gene study is frequently linked to other disciplines of science, such as Transformation efficiency, therefore creating a link between diverse domains of science.
His Haemophilus influenzae research is multidisciplinary, incorporating perspectives in Bacterial adhesin, Virology, Immunity and Otitis.
His work deals with themes such as Streptococcus and Drug resistance, which intersect with Antibiotics.
His Escherichia coli research incorporates elements of Sulfamethoxazole, Internal medicine, Increased risk, Urinary system and Trimethoprim.
Between 2011 and 2021, his most popular works were:
- A Modeling Framework for the Evolution and Spread of Antibiotic Resistance: Literature Review and Model Categorization (76 citations)
- Degradation of Extracellular Antibiotic Resistance Genes with UV254 Treatment (54 citations)
- Mycoplasma, bacterial vaginosis–associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort (51 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Antibiotic resistance, Microbiology, Cefotaxime, Antibiotics and Resistance.
His work in Antibiotic resistance covers topics such as Ampicillin which are related to areas like Sulfamethoxazole, CRISPR and Escherichia coli.
The Microbiology study combines topics in areas such as Plasmid, Genetic diversity and Bacteria.
His studies deal with areas such as Carriage, Virulence factor, Virulence and Gentamicin as well as Cefotaxime.
His Antibiotics study combines topics in areas such as Natural experiment and Epidemiology.
His biological study spans a wide range of topics, including Ecology and Drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
